MENU
SNDX
AS OF
Feb 4, 12:47 PM (EDT)
Price
$20.62
Change
-$0.63 (-2.96%)
Capitalization
1.85B
33 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SNDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SNDX is expected to report earnings to fall 15.41% to -59 cents per share on March 09

Syndax Pharmaceuticals SNDX Stock Earnings Reports
Q4'25
Est.
$-0.59
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.26
Q4'24
Missed
by $0.26
The last earnings report on November 03 showed earnings per share of -69 cents, beating the estimate of -73 cents. With 72.64K shares outstanding, the current market capitalization sits at 1.85B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SNDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SNDX showed earnings on November 03, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SNDX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 Gatehouse Drive
Phone
+1 781 419-1400
Employees
184
Web
https://www.syndax.com